COMMUNIQUÉS West-GlobeNewswire

Multicenter Prospective Study of More Than 4,000 Patients Shows WATS3D Increases Detection of Pre-Cancerous Changes in the Esophagus by Over 80%

22/03/2018 - 14:00

– Data published in United European Gastroenterology Journal and featured in new ASGE Tech Talk video – SUFFERN, N.Y., March 22, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, developer of WATS 3D , or Wide Area [...]

Scientific Review Committee Meets on OncBioMune’s Phase 2 Prostate Cancer Clinical Trial

22/03/2018 - 14:00

BATON ROUGE, La., March 22, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Wildflower Enters Distribution Agreement

22/03/2018 - 13:59

VANCOUVER, British Columbia, March 22, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") entered into a Procurement and Transfer of Goods Agreement with one of [...]

Canada House Wellness Group Update: Abba Medix Grow is Commencing

22/03/2018 - 13:40

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 22, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“ [...]

ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

22/03/2018 - 13:30

-- Peer-reviewed findings show blocking CCR2 provides rapid and sustained renal benefit in well-established models of FSGS -- -- Improvements in renal function with CCR2 inhibition associated with encouraging [...]

GTX Corp Issued New Patent and GPS SmartSoles Win Second Place in Tomorrow’s Care 2018 Awards

22/03/2018 - 13:05

LOS ANGELES, CALIFORNIA , March 22, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) , an IoT platform and global provider of personal location GPS and BLE tracking and monitoring wearable technology announced today the [...]

Sienna Biopharmaceuticals Appoints Caroline Van Hove as Chief Commercial Officer

22/03/2018 - 13:05

WESTLAKE VILLAGE, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced the appointment of Caroline Van Hove as the Company’s first Chief Commercial Officer. Ms. Van [...]

Avid Bioservices Receives Six 2018 CMO Leadership Awards

22/03/2018 - 13:05

TUSTIN, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

2017 Annual Report - DTR 6.3.5 and LR 9.6.1 Disclosures

22/03/2018 - 13:02

2017 Annual Report - DTR 6.3.5 and LR 9.6.1 Disclosures March 22, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that the following documents will today be posted to shareholders: > 2017 Annual [...]

Achaogen Announces New Employment Inducement Grants

22/03/2018 - 13:01

SOUTH SAN FRANCISCO, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects

22/03/2018 - 13:01

SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today [...]

Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel

22/03/2018 - 13:00

REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the results of a clinical trial recently completed at Kaplan Hospital in Rehovot, [...]

Spero Therapeutics to Present at Upcoming Investor Conferences

22/03/2018 - 13:00

CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Envigo to Expand Livermore, California Research Model Surgical Facility to Meet Rising Demand from West Coast Biopharmaceutical Companies

22/03/2018 - 13:00

East Millstone, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of nonclinical contract research services and research models, is investing in an expansion of its research model surgical facility at [...]

Progressive Care Releases Audited 2017 Annual Report

22/03/2018 - 13:00

MIAMI, March 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces 2017 annual results. The Company announced over $20 million in net revenues, a 10% [...]

Zealand Pharma convenes its Annual General Meeting 2018

22/03/2018 - 12:38

Company Announcement - No. 10/2018 Zealand Pharma convenes its Annual General Meeting 2018 Copenhagen, March 22, 2018 - Zealand Pharma A/S ("Zealand") convenes the Company's ordinary Annual General Meeting to be held on [...]

Precipio Restructures Capitalization Table

22/03/2018 - 12:37

NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), in an 8-K issued today announced an agreement with investors in certain 2017 underwritten and registered [...]

Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer

22/03/2018 - 12:30

DUBLIN, Ireland, March 22, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), “Avadel” or the “Company,” today announced the promotion of Gregory J. Divis to Executive Vice President and Chief [...]

Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial

22/03/2018 - 12:30

Significant Improvement in 6MWD in Patients With IPF and Sarcoidosis No Safety Signals Identified IRVING, Texas, March 22, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a [...]